These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 3088240)

  • 21. Serum carnitine levels of children with epilepsy: Related factors including valproate.
    Okumura A; Kurahashi H; Iwayama H; Numoto S
    Brain Dev; 2019 Jun; 41(6):516-521. PubMed ID: 30827788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
    Ohtani Y; Ohyanagi K; Yamamoto S; Matsuda I
    J Pediatr; 1988 Mar; 112(3):409-14. PubMed ID: 3346778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carnitine deficiency: a possible mechanism for valproate hepatotoxicity.
    Coulter DL
    Lancet; 1984 Mar; 1(8378):689. PubMed ID: 6142383
    [No Abstract]   [Full Text] [Related]  

  • 24. Abnormal metabolism of carnitine and valproate in a case of acute encephalopathy during chronic valproate therapy.
    Murakami K; Sugimoto T; Nishida N; Kobayashi Y; Kuhara T; Matsumoto I
    Brain Dev; 1992 May; 14(3):178-81. PubMed ID: 1514659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Carnitine Supplementation on Hyperammonemia and Carnitine Deficiency Treated with Valproic Acid in a Psychiatric Setting.
    Nakamura M; Nagamine T
    Innov Clin Neurosci; 2015; 12(9-10):18-24. PubMed ID: 26634177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carnitine deficiency in inherited organic acid disorders and Reye syndrome.
    Sugiyama N; Kidouchi K; Kobayashi M; Wada Y
    Acta Paediatr Jpn; 1990 Aug; 32(4):410-6. PubMed ID: 2288224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum carnitine, beta-hydroxybutyrate and ammonia levels during valproic acid therapy.
    Toksoy HB; Tanzer FN; Atalay A
    Turk J Pediatr; 1995; 37(1):25-9. PubMed ID: 7732605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal hyperammonemia associated with carnitine deficiency.
    Nagao M; Tsuchiyama A; Mori T; Agatsuma Y; Oyanagi K
    Tohoku J Exp Med; 1989 Aug; 158(4):317-23. PubMed ID: 2588261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesson of the month 1: Sodium valproate-induced encephalopathy.
    Camilleri L
    Clin Med (Lond); 2018 Oct; 18(5):430-432. PubMed ID: 30287443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carnitine deficiency: Risk factors and incidence in children with epilepsy.
    Fukuda M; Kawabe M; Takehara M; Iwano S; Kuwabara K; Kikuchi C; Wakamoto H; Morimoto T; Suzuki Y; Ishii E
    Brain Dev; 2015 Sep; 37(8):790-6. PubMed ID: 25547040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of carnitine supplementation in valproate-induced hyperammonaemia.
    Böhles H; Sewell AC; Wenzel D
    Acta Paediatr; 1996 Apr; 85(4):446-9. PubMed ID: 8740302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-carnitine supplementation in childhood epilepsy: current perspectives.
    De Vivo DC; Bohan TP; Coulter DL; Dreifuss FE; Greenwood RS; Nordli DR; Shields WD; Stafstrom CE; Tein I
    Epilepsia; 1998 Nov; 39(11):1216-25. PubMed ID: 9821988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carnitine-acylcarnitine translocase deficiency: metabolic consequences of an impaired mitochondrial carnitine cycle.
    Röschinger W; Muntau AC; Duran M; Dorland L; IJlst L; Wanders RJ; Roscher AA
    Clin Chim Acta; 2000 Aug; 298(1-2):55-68. PubMed ID: 10876004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of acylcarnitine levels by tandem mass spectrometry in epileptic children receiving valproate and oxcarbazepine.
    Cansu A; Serdaroglu A; Biberoglu G; Tumer L; Hirfanoglu TL; Ezgu FS; Hasanoglu A
    Epileptic Disord; 2011 Dec; 13(4):394-400. PubMed ID: 22258044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation ofserum free carnitine/acylcarnitine levels and left ventricular systolic functions in children with idiopathic epilepsy receiving valproic acid.
    Kulhas Celik I; Tasdemir HA; Ince H; Celik H; Sungur M
    Clin Neurol Neurosurg; 2018 Jul; 170():106-112. PubMed ID: 29772401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of L-carnitine supplementation on acute valproate intoxication.
    Murakami K; Sugimoto T; Woo M; Nishida N; Muro H
    Epilepsia; 1996 Jul; 37(7):687-9. PubMed ID: 8681902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carnitine, valproate, and toxicity.
    Coulter DL
    J Child Neurol; 1991 Jan; 6(1):7-14. PubMed ID: 2002205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine.
    Gidal BE; Inglese CM; Meyer JF; Pitterle ME; Antonopolous J; Rust RS
    Pediatr Neurol; 1997 May; 16(4):301-5. PubMed ID: 9258962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G; Epifanio G; Auricchio G; Federico RR; Resicato G; Pascotto A
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.